Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Laxmi DentalNSE:LAXMIDENTL +0.99%28 EBITDA Margin % is 21.98% as of Mar. 2026, which is 66% above its 10-year median of 13.28. GuruFocus rates NSE:LAXMIDENTL with a GF Score™ of 28/100. The stock has 4 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Laxmi Dental ranks better than 70.13% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Laxmi Dental's EBITDA for the
three
months ended in Mar. 2026 was ₹159 Mil. Laxmi Dental's Revenue for the
three
months ended in Mar. 2026 was ₹722 Mil. Therefore, Laxmi Dental's EBITDA margin for the quarter that ended in Mar. 2026 was 21.98%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Laxmi Dental EBITDA Margin % Related Terms
Laxmi Dental EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Laxmi Dental's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LAXMIDENTL vs ISRG, BDX, MDLN: EBITDA Margin % Comparison
For the Medical Instruments & Supplies subindustry, Laxmi Dental's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Laxmi Dental EBITDA Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Laxmi Dental's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Laxmi Dental's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Laxmi Dental (NSE:LAXMIDENTL) has a EBITDA Margin % of 21.98% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Laxmi Dental and its competitors. This is 66% above median its historical median of 13.28. According to the industry distribution chart, Laxmi Dental ranks #244 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 29.9%.
Is Laxmi Dental's EBITDA Margin % too high?
Laxmi Dental's current EBITDA Margin % of 21.98% is 66% above median its 10-year median of 13.28. The Medical Devices & Instruments industry median EBITDA Margin % is 7.44. Laxmi Dental's value of 21.98% is 195.4% above this industry median. Based on the distribution chart, Laxmi Dental ranks #244 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Laxmi Dental has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Laxmi Dental's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Laxmi Dental ranks #244 out of 817 companies for EBITDA Margin %. This puts Laxmi Dental in the upper half of its industry. The industry median EBITDA Margin % is 7.44. Laxmi Dental's value of 21.98% is 195.4% above this benchmark. While the company's 10-year median is 13.28 vs. the industry median of 7.44, Laxmi Dental has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.44, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Laxmi Dental's current EBITDA Margin % of 21.98% is 195.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Laxmi Dental and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Laxmi Dental's current EBITDA Margin % is 21.98%, which is 66% above median its own 10-year median of 13.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Laxmi Dental stock overvalued right now?
Laxmi Dental (NSE:LAXMIDENTL) has a current EBITDA Margin % of 21.98%. The current EBITDA Margin % is 21.98%, which is 66% above median its 10-year median of 13.28 and 195.4% above the Medical Devices & Instruments industry median of 7.44. Laxmi Dental's overall GF Score™ is 28/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Laxmi Dental (NSE:LAXMIDENTL), the current EBITDA Margin % is 21.98% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Laxmi Dental Ltd is an end-to-end integrated dental products company. Its products include custom-made crowns and bridges, branded dental products such as clear aligners, thermoforming sheets, and aligner-related products as a part of aligner solutions, and paediatric dental products. The Group has three reportable segments: Laboratory Business segment comprises dental prostheses, such as metal-free crowns & bridges, Porcelain Fused to Metal (PFM) Crowns and Bridges, and Dentures. The Aligners Business segment comprises dental aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, and Sleep Apnea Devices. The Other Business segment comprises Dental distribution products used in Dental Laboratory, Dental Clinical Services, and Dental Educational Courses.
28GF Score
Get the complete analysis for NSE:LAXMIDENTL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LAXMIDENTL has been successfully added to your 
